Seqens CDMO North America, a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs), and other specialty chemical products, has appointed Jean-Noel David as managing director for North America. He replaces Ed Price, co-founder and president of the business, who will continue to serve as a consultant.   David’s mission is to grow Seqens’ CDMO business in North America, which includes plans to add manufacturing capacity, equipment and staff. Based on ...